MissionIR Articles
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Schedules Webcast to Discuss 2021 Financial and Operating Results
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced that it will host a webcast at 9 a.m. ET on Tuesday, May 10, to discuss financial and operating results for its fiscal year ended Dec. 31, 2021. During the webcast, Flora’s management will deliver comments on financial…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Demonstrating ‘Encouraging Promise in Treatment of GBM’
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical cancer drug developer, recently reported new advances in its rollout of a global clinical trial described as “potentially pivotal” in producing a treatment for an aggressive brain cancer, glioblastoma multiforme (“GBM”). On average, GBM is nearly 100% fatal just over a year into diagnosis. “CNS announced that France’s regulatory…
-
MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Enters New Shopping Center Contract in Yonkers, New York
Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, today announced that it has executed a new contract with a New York shopping center owner. The announcement reads, “Seven years ago yesterday, on Star Wars Day, Knightscope deployed its first robot at a popular Silicon Valley mall —…
-
MissionIRNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) Preclinical Study Findings to Be Showcased at Global Event Focused on Psychedelic-Assisted Therapy
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that an abstract highlighting preclinical data for its deuterated psilocybin analog CYB003 has been selected for a poster presentation at the “From Research to Reality” Global Summit on Psychedelic-Assisted Therapies and Medicines. The event is slated to take…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Participate in Groundbreaking Study with Trokie and Radicle Science
InMed Pharmaceuticals (NASDAQ: INM) is a leader in the research, development, manufacturing and commercialization of rare cannabinoids. The company today announced that its subsidiary, BayMedica, will be providing rare cannabinoids for use in Radicle Science Inc.’s Radicle Energy rare cannabinoid study to assess the effects of delta-9 (“d-9”) dominant tetrahydrocannabivarin (“THCV”) on energy, focus/attention, appetite…
-
MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Robot Roadshow Takes the Stage in Columbus, Ohio
Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, recently announced that its Robot Roadshow will land at the Ohio Hotel & Lodging Association (“OHLA”) meeting taking place at the Marriott Columbus OSU in Columbus, Ohio, from 10:00 a.m. to 2:00 p.m. ET today. The Robot Roadshow is…
-
MissionIRNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Announces Partnership with IBN for Corporate Communications Needs
Golden Matrix Group (NASDAQ: GMGI), an established gaming technology company that develops and owns online gaming IP and builds turnkey online casino solutions for gaming operators, has selected InvestorBrandNetwork (“IBN”) for its corporate communications needs. IBN is a multifaceted financial news and publishing company that offers communications expertise and solutions for private and public entities.…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters First UST Early Access Manufacturing Agreement
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty services to the worldwide biopharmaceuticals, cosmetics, nutraceuticals, agrochem, and food & beverage industries, has signed its inaugural nanoemulsions development and manufacturing agreement under its recently released Ultra Shear Technology(TM) (“UST”) early-access program. The agreement, signed…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Launches New Skincare Line Ahead of Luxury Meets Cannabis Conference
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced the launch of a new skincare line under its brand, MIND Naturals (“Mind”), ahead of the Luxury Meets Cannabis Conference (“LMCC”) in New York City. Mind is inspired by its Colombian roots and leverages superfruits and nutrients native…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Transition from Pure-Play Pharma R&D Firm Featured in Research Report
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, was featured in a report published by Edison Group, a leading research and investor relations consultancy. The piece details InMed Pharmaceuticals and its continued “transition from a pure-play pharma R&D firm to one also benefiting from commercial sales into…
-
MissionIRNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Launch of Physician-Focused Ads as Part of Large-Scale Campaign Around sugarBEAT(R)
Nemaura Medical (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing wearable diagnostic devices and supporting personalized lifestyle coaching programs. The company today announced that its U.K. licensee, MySugarWatch, as part of a large scale awareness campaign for the company’s sugarBEAT non-invasive continuous glucose monitor, has launched a series of ads in…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Stands Distinct in REE Processing, Production Capabilities
Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based uranium mining company that is also moving faster than any other company to re-establish a domestic rare earth elements (“REE”) supply chain, appears set to benefit from growth of the global REE market. A recent Mordor Intelligence article is reporting that the sector has reached…
-
MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Creating Energy Resources While Solving Growing Waste Problem
EverGen (TSX.V: EVGN) (OTCQB: EVGIF), a leading Canadian renewable energy company and Canada’s renewable natural gas (“RNG”) infrastructure platform, uses innovative systems to capture and process into RNG (energy) harmful greenhouse gases that would otherwise be emitted by organic waste. “Instead of letting methane from animal waste and other biomass sources go directly into the…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) to Participate in Luxury Meets Cannabis Conference
Flora Growth’s (NASDAQ: FLGC) executives Luis Merchan and James Choe are scheduled to participate at the upcoming Luxury Meets Cannabis Conference. The two-day event is scheduled for May 5–6, 2022, in New York City. The premier B2B CBD, hemp and cannabis event — the first of its kind — is an ideal venue to shine a spotlight…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Unlock Capabilities of Revolutionary DehydraTECH(TM) Platform
Lexaria Bioscience Corp. (NASDAQ: LEXX) is aware of the need to continuously improve its understanding of the capabilities and potential applications of its patented DehydraTECH(TM) drug delivery technology. This informs its long-held commitment to its applied research and development (“R&D”) programs. “So far, the company’s research journey has involved a series of controlled and well-designed…
-
MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Advancing Pipeline in Commitment to Transform Mental Health Treatment Landscape
Cybin (NYSE American: CYBN) (NEO: CYBN) is a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions in a commitment to transform the mental health treatment landscape. Through its proprietary deuterated process, Cybin is combining controllable drug-delivery systems with novel psychedelic molecules, thus creating patent-protected, commercially scalable drug candidates.…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Approval from Ethics Committee and Competent Authority in Spain for Potentially Pivotal Study
CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”). The company today announced its receipt of approval from the Spanish Agency for Medicines and Health Products (“AEMPS”) Competent Authority and from the CElm Provincial de Sevilla…
-
MissionIRNewsBreaks – GreenBox POS (NASDAQ: GBOX) to Participate in Taglich Brothers Conference
GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, will be presenting during next month’s Taglich Brothers Investment Conference. The two-day event is scheduled for May 2–3, 2022, and will take place in New York City. GreenBox chair Ben Errez will be presenting during the event. His presentation will include a discussion of the…
-
MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Signs Deal to Provide Three ASRs to San Francisco Bay Area Client
Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies committed to enhancing U.S. security operations, continues to make major progress in its focus on market expansion. The company just announced that a San Francisco Bay Area biotech real estate development will be provided with two of its K5 ASRs and one K1 ASR to…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Patent Portfolio with Novel Cannabinoid Analogs, Initiates Strategic Research Collaboration Agreement
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced the publication of a patent application in North America. The application has broad claims directed to the molecular structure, uses and methods of manufacturing of several cannabinoid analogs. Describing several new cannabinoid-related chemical compounds, the broad patent…
Search Articles
Latest Articles
- Beeline Holdings, Inc. (NASDAQ: BLNE) Clears Debt and Boosts Revenue, On Track to Becoming Cash Flow Positive by Early 2026
- MissionIRNewsBreaks – Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) Highlighted in Cantor Report for Growth Potential and Sector Strength
- MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) to Begin Trading as Solmate (NASDAQ: SLMT) on Oct. 3
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Builds Domestic Supply Chain Using RapidSX Technology
- Forward Industries Inc. (NASDAQ: FORD) Is ‘One to Watch’